Medication management is becoming increasingly challenging for older people, and there is limited evidence to guide medication prescribing and administration for people with multimorbidity, frailty, or at the end of life. Currently, there is a lack of clear research priorities in the field of geriatric pharmacotherapy. To address this issue, international experts from 5 research groups in geriatric pharmacotherapy and pharmacoepidemiology research were invited to attend the inaugural Optimizing Geriatric Pharmacotherapy through Pharmacoepidemiology Network workshop. A modified nominal group technique was used to explore and consolidate the priorities for conducting research in this field. Eight research priorities were elucidated: quality of medication use; vulnerable patient groups; polypharmacy and multimorbidity; person-centered practice and research; deprescribing; methodological development; variability in medication use; and national and international comparative research. The research priorities are discussed in detail in this article with examples of current gaps and future actions presented. These priorities highlight areas for future research in geriatric pharmacotherapy to improve medication outcomes in older people.

Tan, E. C. K., Sluggett, J. K., Johnell, K., Onder, G., Elseviers, M., Morin, L., Vetrano, D. L., Wastesson, J. W., Fastbom, J., Taipale, H., Tanskanen, A., Bell, J. S., Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus, <<JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION>>, 2018; 19 (3): 193-199. [doi:10.1016/j.jamda.2017.12.002] [http://hdl.handle.net/10807/116610]

Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus

Onder, Graziano;Vetrano, Davide L.;
2018

Abstract

Medication management is becoming increasingly challenging for older people, and there is limited evidence to guide medication prescribing and administration for people with multimorbidity, frailty, or at the end of life. Currently, there is a lack of clear research priorities in the field of geriatric pharmacotherapy. To address this issue, international experts from 5 research groups in geriatric pharmacotherapy and pharmacoepidemiology research were invited to attend the inaugural Optimizing Geriatric Pharmacotherapy through Pharmacoepidemiology Network workshop. A modified nominal group technique was used to explore and consolidate the priorities for conducting research in this field. Eight research priorities were elucidated: quality of medication use; vulnerable patient groups; polypharmacy and multimorbidity; person-centered practice and research; deprescribing; methodological development; variability in medication use; and national and international comparative research. The research priorities are discussed in detail in this article with examples of current gaps and future actions presented. These priorities highlight areas for future research in geriatric pharmacotherapy to improve medication outcomes in older people.
Inglese
Tan, E. C. K., Sluggett, J. K., Johnell, K., Onder, G., Elseviers, M., Morin, L., Vetrano, D. L., Wastesson, J. W., Fastbom, J., Taipale, H., Tanskanen, A., Bell, J. S., Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus, <<JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION>>, 2018; 19 (3): 193-199. [doi:10.1016/j.jamda.2017.12.002] [http://hdl.handle.net/10807/116610]
File in questo prodotto:
File Dimensione Formato  
116610.pdf

non disponibili

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 218.3 kB
Formato Unknown
218.3 kB Unknown   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/116610
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 28
social impact